NovaPlex HPV28

Description

{"description":" The Centers for Disease Control and Prevention (CDC) intends to award, on a sole source basis, a purchase/delivery order to: Seegene USA, Inc, 141 Innovation Drive Ste 200, Irvine, CA 92617. The order is for the Novaplex HPV28 Detetion Laboratory Tests. The authority for this sole source procurement is FAR part 13.103-1 (SAP). The contractor shall, provide HPV28 laboratory test. \n\n This is not a request for competitive proposals and no solicitation is available. Firms that believe they can provide the required services are encouraged to identify themselves and give written notification to the Contracting Officer within 10 days from the publication date of this synopsis. A determination by the Government not to compete this proposed action based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. Inquiries may be sent to Phil Alexander by facsimile at 770-488-2067, or by email to PALEXANDER@CDC.GOV. \n\n \n\n \n\n \n"} Solicitation Number: 2026-95234 Type: Combined Synopsis/Solicitation Base Type: Combined Synopsis/Solicitation NAICS: 54138 Classification Code: 6632 Response Deadline: 2026-03-15T04:00:00-04:00 Office Address: ATLANTA, GA Place of Performance: Georgia, 30341 POC: Phil Alexander, pfa5@cdc.gov, 7704882067 POC: Steve Lester, svl3@cdc.gov, 7704881998 {"description":" The Centers for Disease Control and Prevention (CDC) intends to award, on a sole source basis, a purchase/delivery order to: Seegene USA, Inc, 141 Innovation Drive Ste 200, Irvine, CA 92617. The order is for the Novaplex HPV28 Detetion Laboratory Tests. The authority for this sole source procurement is FAR part 13.103-1 (SAP). The contractor shall, provide HPV28 laboratory test. \n\n This is not a request for competitive proposals and no solicitation is available. Firms that believe they can provide the required services are encouraged to identify themselves and give written notification to the Contracting Officer within 10 days from the publication date of this synopsis. A determination by the Government not to compete this proposed action based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. Inquiries may be sent to Phil Alexander by facsimile at 770-488-2067, or by email to PALEXANDER@CDC.GOV. \n\n \n\n \n\n \n"}